The Burden of Non-Motor Symptoms in Parkinson's Disease: A Cross-Sectional Study on Clinical Correlates and Quality of Life in Quetta, Pakistan
DOI:
https://doi.org/10.70749/ijbr.v3i6.1520Keywords:
Parkinson's Disease, Non-Motor Symptoms (NMS), Quality of Life (QoL), Cognitive ImpairmentAbstract
Background: Parkinson's disease (PD) patients' quality of life (QoL) is greatly impacted by non-motor symptoms (NMS), however, there is still a lack of a thorough definition of these symptoms in varied regional populations like Pakistan. This study aimed to delineate non-motor symptoms (NMS), their correlations with clinical characteristics, and their influence on quality of life (QoL) in a cohort of Parkinson's disease (PD) patients from Quetta, Pakistan. Methods: This cross-sectional study encompassed 86 Parkinson's disease patients prospectively recruited from the Neurology Outpatient Department of Bolan Medical Complex Hospital in Quetta. Demographic data, disease features, quality of life (PDQ-39, Schwab & England ADL), and biomarkers were gathered. Statistical analyses encompassed descriptive statistics, bivariate analyses, and multivariate analyses (linear and logistic regression). Results: The study population exhibited a mean age of 64.3±9.1 years, with a male predominance of 67.4%. A significant prevalence of NMS was noted, encompassing cognitive impairment (mean MoCA: 21.8±3.9), severe depression (23.3), and sleep problems (median PDSS-2: 20). Quality of life was markedly diminished (median PDQ-39: 48). Prolonged disease duration (rho = 0.45, p<0.001) and advanced H&Y stage (H = 18.2, p=0.001) were predictive with increased NMS burden. Conclusion: Non-motor symptoms are exceedingly frequent and substantially affect the quality of life in Parkinson's disease patients from Quetta, Pakistan. The advancement of disease and depression are significant indicators of NMS burden. These findings underscore the essential requirement for regular NMS screening and comprehensive care strategies to enhance patient outcomes in this marginalized community.
Downloads
References
Kulcsarova, K., Skorvanek, M., Postuma, R. B., & Berg, D. (2024). Defining Parkinson’s disease: Past and future. Journal of Parkinson’s Disease, 14(s2), S257-S271.
https://doi.org/10.3233/jpd-230411
Dattatraya, C. S., Pandurang, M. S., & Jakir, T. N. (2025). Current perspectives on pathogenesis, clinical manifestations, and treatment of Parkinson's disease. Journal of Pharma Insights and Research, 3(2), 053-062.
https://doi.org/10.69613/t3q3nv23
Tarakad, A. (2025). Motor features of Parkinson’s disease. Neurologic Clinics, 43(2), 279-289.
https://doi.org/10.1016/j.ncl.2024.12.007
Jiang, Y., Yang, H., Kim, J., Tang, Z., & Ruan, X. (2025). Power of multi-modality variables in predicting Parkinson's disease progression. IEEE Journal of Biomedical and Health Informatics, 29(2), 1343-1356.
https://doi.org/10.1109/jbhi.2024.3482180
Tanaka, M., & Vécsei, L. (2024). Correction to: Revolutionizing our understanding of Parkinson’s disease: Dr. Heinz Reichmann’s pioneering research and future research direction. Journal of Neural Transmission.
https://doi.org/10.1007/s00702-024-02847-2
Tapdia, M., Kumar, A., Yadav, A. K., Singh, V. K., Pathak, A., Chaurasia, R. N., Mishra, V. N., Dubey, N. K., Dhiman, N. R., Shailesh, M., & Joshi, D. (2025). Clinical spectrum of non-motor symptoms in correlation with quality of life in Parkinson’s disease and atypical parkinsonism: Evidence in reaching consensus. Annals of Neurosciences.
https://doi.org/10.1177/09727531251321234
Patwardhan, A., Kamble, N., Bhattacharya, A., Holla, V., Yadav, R., & Pal, P. K. (2024). Impact of non-motor symptoms on quality of life in patients with early-onset Parkinson’s disease. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 51(5), 650-659.
https://doi.org/10.1017/cjn.2023.336
Grigoriou, S. (2024). Parkinson's disease: aspects of add-on medications in motor and non-motor symptoms.
El-Mansoury, B., El Khiat, A., Skaou, A., El Hiba, O., Jayakumar, A. R., Hamdan, Y. A., Bitar, A., & Ferssiwi, A. (2025). Non-motor symptoms of Parkinson's disease. Essential Guide to Neurodegenerative Disorders, 269-280.
https://doi.org/10.1016/b978-0-443-15702-8.00017-8
Tam, D. M., Linh, L. T., Trang, D. T., & Thi Ha An, T. (2024). Sleep disturbances and associated factors in patients with Parkinson's disease. Clinical Neurology and Neurosurgery, 244, 108436.
https://doi.org/10.1016/j.clineuro.2024.108436
Park, K. (2024). Neuropsychiatric manifestations in Parkinson’s disease and other Lewy body diseases. Neuropsychiatric Manifestations in Neurological Diseases, 153-161.
https://doi.org/10.1007/978-981-97-1821-4_16
Dodet, P., Houot, M., Leu-Semenescu, S., Corvol, J., Lehéricy, S., Mangone, G., Vidailhet, M., Roze, E., & Arnulf, I. (2024). Sleep disorders in Parkinson’s disease, an early and multiple problem. npj Parkinson's Disease, 10(1).
https://doi.org/10.1038/s41531-024-00642-0
Jerčić, K. G., Blažeković, A., Borovečki, S., & Borovečki, F. (2024). Non-motor symptoms of Parkinson`s disease-insights from genetics. Journal of Neural Transmission, 131(11), 1277-1284.
https://doi.org/10.1007/s00702-024-02833-8
Peña-Zelayeta, L., Delgado-Minjares, K., Rojas, M. V., León-Arcia, K., Santiago-Balmaseda, A., Andrade-Guerrero, J., Pérez-Segura, I., Ortega-Robles, E., Soto-Rojas, L. O., & Arias-Carrión, O. (2025). Non-motor symptoms in Parkinson’s disease.
https://doi.org/10.20944/preprints202503.1395.v1
Peña-Zelayeta, L., Delgado-Minjares, K. M., Villegas-Rojas, M. M., León-Arcia, K., Santiago-Balmaseda, A., Andrade-Guerrero, J., Pérez-Segura, I., Ortega-Robles, E., Soto-Rojas, L. O., & Arias-Carrión, O. (2025). Redefining non-motor symptoms in Parkinson’s disease. Journal of Personalized Medicine, 15(5), 172.
https://doi.org/10.3390/jpm15050172
Xu, H., Zheng, X., Xing, X., Bi, Z., Wang, D., Zhang, C., Wei, L., Jin, Y., & Xu, S. (2025). Advances in autonomic dysfunction research in Parkinson’s disease. Frontiers in Aging Neuroscience, 17.
https://doi.org/10.3389/fnagi.2025.1468895
Mejía, C. A. (2024). Exploring and diving deeper into Parkinson’s disease mechanisms. Therapeutic Exercise for Parkinson's Disease and Related Disorders, 1-23.
https://doi.org/10.1007/978-3-031-62119-2_1
Niemi, K. J. FUNCTION AND SYMPTOMS OF PARKINSON’S DISEASE.
Aamodt, W. W., Willis, A. W., & Dahodwala, N. (2023). Racial and ethnic disparities in Parkinson disease. Neurology Clinical Practice, 13(2).
https://doi.org/10.1212/cpj.0000000000200138
Hamedani, A. G., Auinger, P., Willis, A. W., Safarpour, D., Shprecher, D., Stover, N., Subramanian, T., & Cloud, L. (2023). Adjusting for underrepresentation reveals widespread underestimation of Parkinson's disease symptom burden. Movement Disorders, 38(9), 1679-1687.
https://doi.org/10.1002/mds.29507
Rodriguez‐Blazquez, C., Schrag, A., Rizos, A., Chaudhuri, K. R., Martinez‐Martin, P., & Weintraub, D. (2020). Prevalence of non‐motor symptoms and non‐motor fluctuations in Parkinson's disease using the MDS‐NMS. Movement Disorders Clinical Practice, 8(2), 231-239.
https://doi.org/10.1002/mdc3.13122
Bloem, B. R., Okun, M. S., & Klein, C. (2021). Parkinson's disease. The Lancet, 397(10291), 2284-2303.
https://doi.org/10.1016/s0140-6736(21)00218-x
Prajjwal, P., Flores Sanga, H. S., Acharya, K., Tango, T., John, J., Rodriguez, R. S., Dheyaa Marsool Marsool, M., Sulaimanov, M., Ahmed, A., & Hussin, O. A. (2023). Parkinson’s disease updates: Addressing the pathophysiology, risk factors, genetics, diagnosis, along with the medical and surgical treatment. Annals of Medicine & Surgery, 85(10), 4887-4902.
https://doi.org/10.1097/ms9.0000000000001142
Postuma, R. B., Berg, D., Stern, M., Poewe, W., Olanow, C. W., Oertel, W., Obeso, J., Marek, K., Litvan, I., Lang, A. E., Halliday, G., Goetz, C. G., Gasser, T., Dubois, B., Chan, P., Bloem, B. R., Adler, C. H., & Deuschl, G. (2015). MDS clinical diagnostic criteria for Parkinson's disease. Movement Disorders, 30(12), 1591-1601.
https://doi.org/10.1002/mds.26424
Goetz, C. G., Tilley, B. C., Shaftman, S. R., Stebbins, G. T., Fahn, S., Martinez‐Martin, P., ... & LaPelle, N. (2008). Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): scale presentation and clinimetric testing results. Movement disorders: official journal of the Movement Disorder Society, 23(15), 2129-2170.
https://doi.org/10.1002/mds.22340
Tomlinson, C. L., Stowe, R., Patel, S., Rick, C., Gray, R., & Clarke, C. E. (2010). Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Movement Disorders, 25(15), 2649-2653.
https://doi.org/10.1002/mds.23429
Nasreddine, Z. S., Phillips, N. A., Bédirian, V., Charbonneau, S., Whitehead, V., Collin, I., Cummings, J. L., & Chertkow, H. (2005). The Montreal cognitive assessment, MoCA: A brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society, 53(4), 695-699.
https://doi.org/10.1111/j.1532-5415.2005.53221.x
Trenkwalder, C., Kohnen, R., Högl, B., Metta, V., Sixel‐Döring, F., Frauscher, B., Hülsmann, J., Martinez‐Martin, P., & Chaudhuri, K. R. (2011). Parkinson's disease sleep scale—validation of the revised version PDSS‐2. Movement Disorders, 26(4), 644-652.
https://doi.org/10.1002/mds.23476
Visser, M., Marinus, J., Stiggelbout, A. M., & Van Hilten, J. J. (2004). Assessment of autonomic dysfunction in Parkinson's disease: The SCOPA‐AUT. Movement Disorders, 19(11), 1306-1312.
https://doi.org/10.1002/mds.20153
Doty, R. L., Shaman, P., Kimmelman, C. P., & Dann, M. S. (1984). University of Pennsylvania smell identification test: A rapid quantitative olfactory function test for the clinic. The Laryngoscope, 94(2), 176-178.
https://doi.org/10.1288/00005537-198402000-00004
Chaudhuri, K. R., Rizos, A., Trenkwalder, C., Rascol, O., Pal, S., Martino, D., Carroll, C., Paviour, D., Falup-Pecurariu, C., Kessel, B., Silverdale, M., Todorova, A., Sauerbier, A., Odin, P., Antonini, A., & Martinez-Martin, P. (2015). King's Parkinson's disease pain scale, the first scale for pain in PD: An international validation. Movement Disorders, 30(12), 1623-1631. https://doi.org/10.1002/mds.26270.
Gonzalez-Latapi, P., Bayram, E., Litvan, I., & Marras, C. (2021). Cognitive impairment in Parkinson’s disease: Epidemiology, clinical profile, protective and risk factors. Behavioral Sciences, 11(5), 74.
https://doi.org/10.3390/bs11050074
Prange, S., Klinger, H., Laurencin, C., Danaila, T., & Thobois, S. (2022). Depression in patients with Parkinson’s disease: Current understanding of its neurobiology and implications for treatment. Drugs & Aging, 39(6), 417-439.
https://doi.org/10.1007/s40266-022-00942-1
Liguori, C., De Franco, V., Cerroni, R., Spanetta, M., Mercuri, N. B., Stefani, A., Pierantozzi, M., & Di Pucchio, A. (2021). Sleep problems affect quality of life in Parkinson's disease along disease progression. Sleep Medicine, 81, 307-311.
https://doi.org/10.1016/j.sleep.2021.02.036
Shkodina, A. D., Tarianyk, K. A., Delva, M. Y., Khan, A. A., Malik, A., Fatima, S., Alexiou, A., Rahman, M. H., & Papadakis, M. (2025). Influence of sleep quality, excessive daytime sleepiness, circadian features and motor subtypes on depressive symptoms in Parkinson's disease. Sleep Medicine, 125, 57-64.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Indus Journal of Bioscience Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
